Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/07/1999US5998421 Lipid metabolism ameliorants
12/07/1999US5998420 Administering an enzyme inhibitor
12/07/1999US5998419 Bactericides
12/07/1999US5998418 Enrofloxacine injection or infusion solutions
12/07/1999US5998417 N-[(4-heteroaryl-1-piperazinyl) alkyl]phthalimides and related compounds and their therapeutic utility
12/07/1999US5998413 Fungicide
12/07/1999US5998411 Viricides
12/07/1999US5998409 Condensed indole derivatives as 5HT4 -receptor antagonists
12/07/1999US5998408 Autoimmune diseases; antiinflammatory agents
12/07/1999US5998406 Bactericides
12/07/1999US5998405 Psychological disorders
12/07/1999US5998404 Nervous system disorders
12/07/1999US5998403 Salts of azelastine having improved solubility useful at providing a cytoprotective effect
12/07/1999US5998402 Osteoporosis; cardiovascular disorders; anticancer agents;postmemopause therapy
12/07/1999US5998401 Naphthyl compounds, intermediates, compositions, and methods
12/07/1999US5998400 Atherosclerosis
12/07/1999US5998398 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity
12/07/1999US5998397 Gallium complexes of 3-Hydroxy-4-pyrones to treat or prevent bone disease
12/07/1999US5998396 Oil solubilized solutions and foods containing phytosterols and process for their production
12/07/1999US5998395 Methods of treating inflammatory dermatosis
12/07/1999US5998394 Compositions for treating skin conditions by enhancing the activity of 1,25(OH)2 D3 using an RXR ligand and/or a 24-hydroxylase inhibitor
12/07/1999US5998393 Methods for assessing 1,25(OH)2 D3 activity in skin and for enhancing the therapeutic use of 1,25(OH)2 D3
12/07/1999US5998392 Benzoyl peroxide flocculent materials and methods of their preparation
12/07/1999US5998390 Combination of bisphosphonate and tetracycline
12/07/1999US5998388 Adenosine derivatives
12/07/1999US5998387 Method for using A1 adenosine receptor agonists
12/07/1999US5998386 Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue
12/07/1999US5998383 Antitumor antisense sequences directed against ribonucleotide reductase
12/07/1999US5998380 Treatment of migraine
12/07/1999US5998377 Administration of lh-rh antagonist cetrorelix in combination with at least one .alpha.-reductase inhibitor; without the side effects associated with testosterone levels being in a castration range.
12/07/1999US5998364 Component B as cicatrizant
12/07/1999US5998193 Genetic engineering
12/07/1999US5998172 Anti-CD6 ligand antibodies
12/07/1999US5998166 Human cd16-ii variants, dna sequences coding for them, their use in therapy and/or in diagnosis of autoimmune diseases and inflammatory illnesses.
12/07/1999US5998140 Complexes of cell with oligomer
12/07/1999US5998137 To assess predisposition or susceptibility to a number of diseases: osteoporosis, atherosclerosis, cancer and immune disorders.
12/07/1999US5997943 Compound for a non-wettable coating, process for treatment of glass with the aid of the compound and products obtained
12/07/1999US5997915 Natural isomers of tetrahydrofolic acid derivatives
12/07/1999US5997905 Preparation of pharmaceutically active particles
12/07/1999US5997903 Oral-administration forms of a medicament containing pantoprazol
12/07/1999US5997897 Process for the production of a transdermal therapeutic system comprising the active substance 17-β-estradiol (anhydrous)
12/07/1999US5997893 Alcohol based anti-microbial compositions with cosmetic appearance
12/07/1999US5997891 Materials and methods utilizing a temporary visual indicator
12/07/1999US5997885 Cosmetic and/or dermatological composition containing thermal spring water or mineral water and an active agent, in order to combat acne or aging
12/07/1999US5997884 Administering droperidol
12/07/1999US5997875 Herbal composition and treatment methods
12/07/1999US5997874 Dihydrophenanthrene
12/07/1999CA2215716C Aerosol delivery of liposome-encapsulated fluoroquinolone
12/07/1999CA2214575C Paroxetine tablets and process to prepare them
12/07/1999CA2211522C Novel compounds
12/07/1999CA2198231C Dihydropyridine derivatives as bradykinin antagonists
12/07/1999CA2184170C Inhibition of hair growth
12/07/1999CA2180717C Use of phosphorus derivatives of alkaloids for treating endocrinopathies
12/07/1999CA2162248C Liquid antacid compositions
12/07/1999CA2161886C Heteroatom substituted alkylbenzylaminoquinuclidines
12/07/1999CA2161103C Controlled release oxybutynin formulations
12/07/1999CA2157410C Enhanced circulation effector composition and method
12/07/1999CA2140768C A method of increasing creatine supply depot
12/07/1999CA2103793C Solvent system to be enclosed in capsules
12/07/1999CA2013037C Aminobenzenesulfonic acid derivative
12/07/1999CA2012686C Treatment and compounds
12/07/1999CA2007740C Substituted quinolinecarboxylic acids
12/07/1999CA2005846C Skin treatment method
12/07/1999CA2004991C Deletion analogues of magainin peptides
12/07/1999CA2002552C Pharmaceutical aqueous solution for ophthalmic use comprising a water solube pharmaceutically acceptable acid addition salt of ibopamine
12/07/1999CA2000744C Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
12/03/1999CA2240002A1 Method of decreasing atherosclerosis and its complications
12/02/1999WO1999061913A2 Improvements in or relating to diagnosis and treatment of bacterial infections
12/02/1999WO1999061745A1 Arrangement for the removal of cuttings and gas arising from drilling operations
12/02/1999WO1999061618A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999WO1999061607A2 Antisense oligonucleotides for treating proliferating cells
12/02/1999WO1999061602A1 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products
12/02/1999WO1999061600A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
12/02/1999WO1999061481A1 Amphiphilic polysaccharide derivatives
12/02/1999WO1999061465A1 Phenylalanine derivatives having vla-4 antagonistic activity
12/02/1999WO1999061463A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999WO1999061462A1 Antisense modulation of cellular adhesion molecule expression and treatment of cellular adhesion molecule-associated diseases
12/02/1999WO1999061453A2 priA
12/02/1999WO1999061451A1 Platinum complex, its preparation and therapeutic application
12/02/1999WO1999061450A1 Platinum complex, its preparation and therapeutic application
12/02/1999WO1999061448A1 Naphthosulfamylmethyl penem antibacterials
12/02/1999WO1999061446A1 G-csf mimetics
12/02/1999WO1999061445A1 G-csf mimetics
12/02/1999WO1999061444A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/02/1999WO1999061442A1 Imidazopyridine thrombin inhibitors
12/02/1999WO1999061440A1 Novel substituted imidazole compounds
12/02/1999WO1999061439A1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
12/02/1999WO1999061438A1 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
12/02/1999WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999WO1999061435A1 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia
12/02/1999WO1999061431A1 New dipeptidyl peptidase iv effectors
12/02/1999WO1999061430A1 Benzofuroxan derivatives and their use in treating angina pectoris
12/02/1999WO1999061428A1 Quinazolines for treating brain tumor
12/02/1999WO1999061427A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999WO1999061424A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
12/02/1999WO1999061423A1 New heterocyclically substituted amides, their production and their use
12/02/1999WO1999061422A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
12/02/1999WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/02/1999WO1999061420A1 3-[(1--n-methylamino)ethyl-n-benzyl] pyrrolidine monomethanesulfonate
1 ... 6400 6401 6402 6403 6404 6405 6406 6407 6408 6409 6410 6411 6412 6413 6414 6415 6416 6417 6418 6419 6420 ... 7860